An alternative to Unibase/glycol as an effective nonhydrating electrolyte medium for the measurement of electrodermal activity.

PubWeight™: 1.23‹?› | Rank: Top 10%

🔗 View Article (PMID 12212634)

Published in Psychophysiology on July 01, 2002

Authors

Sharon L Dormire1, Janet S Carpenter

Author Affiliations

1: University of Michigan School of Nursing, Ann Arbor, USA. Sdormire@umich.edu

Articles citing this

Hot flashes and cardiac vagal control during women's daily lives. Menopause (2012) 1.78

Are vasomotor symptoms associated with sleep characteristics among symptomatic midlife women? Comparisons of self-report and objective measures. Menopause (2012) 1.65

Improving the performance of physiologic hot flash measures with support vector machines. Psychophysiology (2009) 1.54

Laboratory and ambulatory evaluation of vasomotor symptom monitors from the Menopause Strategies Finding Lasting Answers for Symptoms and Health network. Menopause (2012) 1.03

Support Vector Machines to improve physiologic hot flash measures: application to the ambulatory setting. Psychophysiology (2010) 1.02

Adiposity and hot flashes in midlife women: a modifying role of age. J Clin Endocrinol Metab (2011) 0.98

A randomised controlled trial of a cognitive behavioural intervention for women who have menopausal symptoms following breast cancer treatment (MENOS 1): trial protocol. BMC Cancer (2011) 0.93

Magnitude of the impact of hot flashes on sleep in perimenopausal women. Fertil Steril (2014) 0.91

Vagal withdrawal during hot flashes occurring in undisturbed sleep. Menopause (2013) 0.84

Menopausal hot flashes and white matter hyperintensities. Menopause (2016) 0.80

The effect of dietary intake on hot flashes in menopausal women. J Obstet Gynecol Neonatal Nurs (2007) 0.79

Physical activity and sleep among midlife women with vasomotor symptoms. Menopause (2013) 0.79

A randomised controlled trial of cognitive-behavioural therapy for women with problematic menopausal hot flushes: MENOS 2 trial protocol. BMJ Open (2011) 0.78

Sternal skin conductance: a reasonable surrogate for hot flash measurement? Menopause (2013) 0.78

Menopausal hot flashes and the default mode network. Fertil Steril (2015) 0.77

Behavioral weight loss for the management of menopausal hot flashes: a pilot study. Menopause (2015) 0.77

Acute stress alters autonomic modulation during sleep in women approaching menopause. Psychoneuroendocrinology (2015) 0.76

Changes in heart rate variability during vasomotor symptoms among midlife women. Menopause (2016) 0.76

Hypnosis for hot flashes among postmenopausal women study: a study protocol of an ongoing randomized clinical trial. BMC Complement Altern Med (2011) 0.75

Norepinephrine activity, as measured by MHPG, is associated with menopausal hot flushes. Climacteric (2008) 0.75

Articles by these authors

Efficacy of escitalopram for hot flashes in healthy menopausal women: a randomized controlled trial. JAMA (2011) 2.70

Efficacy of exercise for menopausal symptoms: a randomized controlled trial. Menopause (2014) 1.67

Effects of escitalopram on menopause-specific quality of life and pain in healthy menopausal women with hot flashes: a randomized controlled trial. Maturitas (2012) 1.49

Relapse of vasomotor symptoms after discontinuation of the selective serotonin reuptake inhibitor escitalopram: results from the menopause strategies: finding lasting answers for symptoms and health research network. Menopause (2013) 1.45

Efficacy of omega-3 for vasomotor symptoms treatment: a randomized controlled trial. Menopause (2014) 1.44

Efficacy of yoga for vasomotor symptoms: a randomized controlled trial. Menopause (2014) 1.44

Sleep wake disturbances in people with cancer and their caregivers: state of the science. Oncol Nurs Forum (2005) 1.43

Effects of estrogen and venlafaxine on menopause-related quality of life in healthy postmenopausal women with hot flashes: a placebo-controlled randomized trial. Menopause (2015) 1.40

Methods for the design of vasomotor symptom trials: the menopausal strategies: finding lasting answers to symptoms and health network. Menopause (2014) 1.31

Comparison of subjective and objective hot flash measures over time among breast cancer survivors initiating aromatase inhibitor therapy. Menopause (2009) 1.24

Somatic symptoms in patients with cancer experiencing pain or depression: prevalence, disability, and health care use. Arch Intern Med (2010) 1.22

The Indiana University telephone-based assessment of neuropsychological status: a new method for large scale neuropsychological assessment. J Int Neuropsychol Soc (2007) 1.16

Systematic review of health-related quality of life models. Health Qual Life Outcomes (2012) 1.13

The association of depression and pain with health-related quality of life, disability, and health care use in cancer patients. J Pain Symptom Manage (2010) 1.12

Prevalence, severity, and correlates of sleep-wake disturbances in long-term breast cancer survivors. J Pain Symptom Manage (2010) 1.10

Impact of perceived cognitive impairment in breast cancer survivors. Eur J Oncol Nurs (2012) 1.07

Design and methods of a multi-site, multi-behavioral treatment trial for menopausal symptoms: the MsFLASH experience. Contemp Clin Trials (2013) 1.05

The Indiana Cancer Pain and Depression (INCPAD) trial Design of a telecare management intervention for cancer-related symptoms and baseline characteristics of study participants. Gen Hosp Psychiatry (2009) 1.04

Predictors of cancer-related fatigue in women with breast cancer before, during, and after adjuvant therapy. Cancer Nurs (2008) 1.00

Stress, optimism, and social support: impact on immune responses in breast cancer. Res Nurs Health (2007) 1.00

Psychological impact of benign breast biopsy: a longitudinal, comparative study. Health Psychol (2002) 0.97

Genetic associations with toxicity-related discontinuation of aromatase inhibitor therapy for breast cancer. Breast Cancer Res Treat (2013) 0.96

Advanced cognitive training for breast cancer survivors: a randomized controlled trial. Breast Cancer Res Treat (2012) 0.93

A review of music-based intervention reporting in pediatrics. J Health Psychol (2009) 0.92

Cognitive Dysfunction and Its Relationship to Quality of Life in Breast Cancer Survivors. Oncol Nurs Forum (2009) 0.90

Reporting guidelines for music-based interventions. J Health Psychol (2010) 0.88

Clinical hypnosis in the treatment of postmenopausal hot flashes: a randomized controlled trial. Menopause (2013) 0.86

The Impact of Information Technology on Patient Engagement and Health Behavior Change: A Systematic Review of the Literature. JMIR Med Inform (2016) 0.86

Impact of benign breast biopsy upon breast self-examination. Prev Med (2004) 0.84

Risk factors, pathophysiology, and treatment of hot flashes in cancer. CA Cancer J Clin (2013) 0.84

Feasibility study of acupuncture for reducing sleep disturbances and hot flashes in postmenopausal breast cancer survivors. Clin Nurse Spec (2012) 0.84

Finding the Patient's Voice Using Big Data: Analysis of Users' Health-Related Concerns in the ChaCha Question-and-Answer Service (2009-2012). J Med Internet Res (2016) 0.83

Factor analysis of the Pittsburgh Sleep Quality Index in breast cancer survivors. J Pain Symptom Manage (2012) 0.83

Medication use in breast cancer survivors compared to midlife women. Support Care Cancer (2013) 0.82

Cognitive function in breast cancer survivors compared to healthy age- and education-matched women. Clin Neuropsychol (2009) 0.81

Cytochrome P450 polymorphisms and their relationship with premature ovarian failure in premenopausal women with breast cancer receiving doxorubicin and cyclophosphamide. Breast J (2011) 0.78

Systematic review of sleep disorders in cancer patients: can the prevalence of sleep disorders be ascertained? Cancer Med (2014) 0.78

Reporting Guidelines for Music-based Interventions. Music Med (2011) 0.78

Nighttime variability in wrist actigraphy. J Nurs Meas (2011) 0.78

Costs of hormonal and nonhormonal prescription medications for hot flashes. Womens Health (Lond Engl) (2009) 0.77

Theories, models, and frameworks related to sleep-wake disturbances in the context of cancer. Cancer Nurs (2009) 0.77

Exploratory study evaluating the association of polymorphisms of angiogenesis genes with hot flashes. Breast Cancer Res Treat (2008) 0.77

Venlafaxine in management of hot flashes in women with breast cancer: a systematic review and meta-analysis. Breast Cancer Res Treat (2015) 0.77

Symptom clusters among MsFLASH clinical trial participants. Menopause (2016) 0.76

Methodological issues in the investigation of ginseng as an intervention for fatigue. Clin Nurse Spec (2006) 0.76

Pooled Analysis of Six Pharmacologic and Nonpharmacologic Interventions for Vasomotor Symptoms. Obstet Gynecol (2015) 0.76

Evaluating the role of serotonin on neuropsychological function after breast cancer using acute tryptophan depletion. Biol Res Nurs (2010) 0.76

Predicting outcomes among adolescents with disruptive disorders being treated in a system of care program. J Am Psychiatr Nurses Assoc (2013) 0.75

Confirmatory factor analysis of the Pittsburgh Sleep Quality Index in women with hot flashes. Menopause (2015) 0.75

Placebo improvement in pharmacologic treatment of menopausal hot flashes: time course, duration, and predictors. Psychosom Med (2015) 0.75

Oral Endocrine Therapy Nonadherence, Adverse Effects, Decisional Support, and Decisional Needs in Women With Breast Cancer. Cancer Nurs (2016) 0.75

Description of an Audio-Based Paced Respiration Intervention for Vasomotor Symptoms. Music Med (2013) 0.75

Anxiogenic CO2 stimulus elicits exacerbated hot flash-like responses in a rat menopause model and hot flashes in postmenopausal women. Menopause (2016) 0.75

Designing cost-efficient randomized trials by using flexible recruitment strategies. BMC Med Res Methodol (2012) 0.75

Flash points. J Clin Oncol (2007) 0.75

Complexities of Medication Management Across Care Transitions: A Case Report. Clin Nurse Spec (2015) 0.75

Hypnotic relaxation therapy for reduction of hot flashes in postmenopausal women: examination of cortisol as a potential mediator. Int J Clin Exp Hypn (2015) 0.75

When Co-Authors Are Missing in Action. West J Nurs Res (2016) 0.75

State of the Science: Taxane-Induced Musculoskeletal Pain. Cancer Nurs (2016) 0.75

Feasibility and Potential Benefits of a Self-Monitoring Enhanced Lifestyle Intervention to Prevent Excessive Gestational Weight Gain in Women Who Are Overweight and Obese. J Obstet Gynecol Neonatal Nurs (2017) 0.75

Estimating minimally important differences for the PROMIS® Pain Interference Scales: results from three randomized clinical trials. Pain (2017) 0.75

Evaluating the Sleep Hygiene Awareness and Practice Scale in Midlife Women With and Without Breast Cancer. J Nurs Meas (2016) 0.75

Representations of vaginal symptoms in cervical cancer survivors. Cancer Nurs (2009) 0.75